Efficacy and Safety of Influenza Vaccine During Sarcoidosis

Clinical trial NCT01687517 · COMPLETED

Trial details

NCT number: NCT01687517
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Sarcoidosis Influenza Vaccine

Start date: 2012-10-01
Primary completion: 2013-06-01
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.